PL Capital Highlights Growth Potential in Adani Group Stocks Goldman Sachs Latest US Sanctions on Russia Have Limited Impact on Crude Exports Indirect Anthropic Exposure A Potential Public Market Play Burberry Shares Jump on Speculation of Potential Moncler Takeover Bid BHP Acknowledges Emissions Reduction Setbacks as WA Premier Urges Mining Sector to Prioritise Decarbonisation UK Spy Chief Warns of Growing Threats From Russia and China Geopolitical Risks Loom for Global Markets Ambow Education AMBO Q1 2012 Earnings EPS of 26700 Misses 8843 Estimate by 40194 Stock Rises 569 Village Super Market Inc Q1 2025 Earnings Strong EPS Amid Quiet Revenue Disclosure BlackRock BLK Q1 2026 Earnings EPS Beat Drives Modest Stock Gain AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline CMMB Q1 2026 Earnings EPS Misses Estimates as Stock Surges on Pipeline Progress BHC Q1 2026 Earnings EPS Surprises to the Upside Amidst Operational Execution GrabAGun Digital Holdings PEW Dips 214 as Traders Eye 260 Support Zone Silexion Therapeutics SLXN Modest Gains as Stock Holds Key Support at 046 Alussa Energy Acquisition Corp II ALUB Trading Flat Near NAV SPAC Holds Steady at 1001 Northwest Natural Holding NWN Edges Lower Amid Modest Trading Key Levels in Focus NRG Energy Sheds 17 as Shares Test Key Support Levels Coal India Stake Sale Government Sets OFS Floor Price at Rs 412 Discounted from Market FITBM Q1 2026 Earnings Strong EPS Surprise of 35 Driven by Solid Operating Performance Molina Healthcare Shows Modest Gains as Sector Tailwinds Support MOH Weyco Group Inc WEYS Q1 2026 Earnings Solid EPS Performance Amidst Quiet Quarter SAQ Q1 2026 Earnings Steep EPS Miss Clouds Outlook for BDC ECL Q1 2026 Earnings EPS Misses Estimates Modestly Stock Rises on Operational Strength EZRA Q1 2023 Earnings Massive EPS Beat Drives Stock Surge UTHR Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges PEW Q1 2026 Earnings EPS Surprises Positively Despite Broader Market Pressure MLTX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline